Mesangial cell turnover: effect of heparin and peptide growth factors
Striker, L.J.; Peten, E.P.; Elliot, S.J.; Doi, T.; Striker, G.E.
Laboratory Investigation; a Journal of Technical Methods and Pathology 64(4): 446-456
1991
ISSN/ISBN: 0023-6837 PMID: 2016850 Document Number: 377108
Document emailed within 1 workday
Related Documents
Zhang, M.; Guo, M.; Jin, H. 1995: Inhibitory effect of heparin on glomerular mesangial cell Zhonghua Yi Xue Za Zhi 75(5): 273-275; 319Yamashita, W.; MacCarthy, E.P.; Hsu, A.; Gartside, P.S.; Ooi, B.S. 1989: The effect of transforming growth factor-beta on mouse mesangial cell proliferation Clinical and Experimental Immunology 77(2): 285-288
Kiziun, S.M.; Poletaeva, O.A.; Afanasenko, G.A. 1991: Heparin-bound growth factors produced by the established RH-PA cell line Tsitologiia 33(5): 48-53
Wenzel, S.; Stolte, H.; Soose, M. 1996: Effects of silibinin and antioxidants on high glucose-induced alterations of fibronectin turnover in human mesangial cell cultures Journal of Pharmacology and Experimental Therapeutics 279(3): 1520-1526
Tiozzo, R.; Reggiani, D.; Croce, M.A.; Calandra, S.; Osima, B.; Bianchini, P. 1997: Effect of heparin on cell proliferation: lack of correlation with heparin binding sites on cell membrane Drugs under Experimental and Clinical Research 23(3-4): 103-109
Qiu, W.-C.; Wang, Z.-G.; Wang, W.-G.; Zheng, Q. 2008: Effect and mechanism of ghrelin and its synthetic peptide growth hormone releasing peptide 6 on gastric motor in mice Zhonghua Wei Chang Wai Ke Za Zhi 11(2): 172-176
Patel, P.; Varghese, E.; Ding, G.; Fan, S.; Kapasi, A.; Reddy, K.; Franki, N.; Nahar, N.; Singhal, P. 2000: Transforming growth factor beta induces mesangial cell apoptosis through NO- and p53-dependent and -independent pathways Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 48(6): 403-410
Canalis, E. 1985: Effect of growth factors on bone cell replication and differentiation Clinical Orthopaedics and Related Research 193: 246-263
Paul, D. 1985: Growth factors, oncogenes and transformation. Part I: Growth factors and cell cycle control Arzneimittel-Forschung 35(4): 772-779
Zhao, G.; Tong, T. 1995: Prospects of clinical uses of peptide growth factors Zhonghua Yi Xue Za Zhi 75(6): 375-377
Rieber, M.; Bacalao, J.; Alonso, G. 1975: Turnover of high-molecular-weight cell surface proteins during growth and expression of malignant transformation Cancer Research 35(8): 2104-2108
Wu, W.Ka.Kei.; Shin, V.Yvonne.; Ye, Y.Ni.; Wong, H.Pui.Shan.; Huang, F.Yu.; Hui, M.King.Cheung.; Lam, E.Kai.Yee.; Cho, C.Hin. 2006: Heparin increases human gastric carcinoma cell growth Anticancer Research 26(1a): 439-443
Di Paolo, S.; Grandaliano, G.; Gesualdo, L.; Ranieri, E.; Schena, F.P. 1998: Additive effect of cyclosporine and low density lipoproteins on transforming growth factor-beta 1 and monocyte chemotactic protein-1 expression in human mesangial cells Transplantation Proceedings 30(5): 2051
Kunicka, J.E.; Fox, F.E.; Seki, H.; Oleszak, E.L.; Platsoucas, C.D. 1991: Hybridoma-derived human suppressor factors: inhibition of growth of tumor cell lines and effect on cytotoxic cells Human Antibodies and Hybridomas 2(3): 160-169
White, M.M.; Siders, L.; Jennings, L.K.; White, F.L. 1992: The effect of residual heparin on the interpretation of heparin-induced platelet aggregation in the diagnosis of heparin-associated thrombocytopenia Thrombosis and Haemostasis 68(1): 88
Völker, W.; Böhm, A.; Schmidt, A.; Svahn, C.M.; Gellerbring, A.K.; Mattsson, C.; Ekvärn, S.; Robenek, H.; Buddecke, E. 1995: Inhibition of smooth muscle cell proliferation and neointimal growth by low-anticoagulant heparin Arzneimittel-Forschung 45(5): 546-550
Sakamoto, N.; Tanaka, N.G.; Tohgo, A.; Osada, Y.; Ogawa, H. 1987: Inhibitory effects of heparin plus cortisone acetate on endothelial cell growth both in cultures and in tumor masses Journal of the National Cancer Institute 78(3): 581-585
Krasil'nikov, M.A.; Bezrukov, V.M.; Shatskaia, V.A. 1992: Regulation of the phospholipid turnover rate and protein kinase C activity as a necessary stage in the realization of the growth-inhibiting effect of dexamethasone on hepatoma 22 cells Biokhimiia 57(4): 627-636
Dorn, G.W.; Becker, M.W. 1992: Growth factors downregulate vascular smooth muscle thromboxane receptors independent of cell growth American Journal of Physiology 262(4 Pt 1): C927-C933
Rueda, F.; Piñol, G.; Gonzalez-Garrigues, M.; Marti, F.; Fabra, A. 1989: Transforming growth factor release by human tumor cell lines and their interactions with other growth factors Anticancer Research 9(4): 1245-1248